Approval Year
Substance Class |
Protein
Created
by
admin
on
Edited
Tue Apr 01 20:35:23 GMT 2025
by
admin
on
Tue Apr 01 20:35:23 GMT 2025
|
Protein Sub Type | |
Sequence Type | COMPLETE |
Record UNII |
F05Y5QQX44
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
F05Y5QQX44
Created by
admin on Tue Apr 01 20:35:23 GMT 2025 , Edited by admin on Tue Apr 01 20:35:23 GMT 2025
|
PRIMARY | |||
|
P10747
Created by
admin on Tue Apr 01 20:35:23 GMT 2025 , Edited by admin on Tue Apr 01 20:35:23 GMT 2025
|
PRIMARY |
From | To |
---|---|
1_22 | 1_94 |
1_48 | 1_68 |
Glycosylation Type | HUMAN |
Glycosylation Link Type | Site |
---|---|
N | 1_19 |
N | 1_53 |
N | 1_74 |
N | 1_87 |
N | 1_111 |
Related Record | Type | Details | ||
---|---|---|---|---|
|
INHIBITOR -> TARGET |
|
||
|
LIGAND->TARGET |
|
||
|
AGONIST -> TARGET | |||
|
ACTIVATOR -> TARGET |
GI101 has high binding affinity to CTLA4 acting as a decoy ligand, thereby enhancing the interaction between endogenous CD80 and CD28, leading to the activation of T cells
IN-VIVO
|
||
|
AGONIST -> TARGET |
|
||
|
INHIBITOR -> TARGET | |||
|
ACTIVATOR -> TARGET |
T cell activation can also be achieved by agonistic stimulation with the CD3 antibody binding to the TCR complex and can be enhanced by costimulation with CD28 antibody.
|
||
|
DERIVATIVE -> PARENT |
Structural Modifications
Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
---|---|---|---|---|---|---|
AMINO ACID SUBSTITUTION | [1_173] [1_191] | TYROSINE O-PHOSPHATE | 2R86C98KDX | |||
AMINO ACID SUBSTITUTION | [1_171] | DEXFOSFOSERINE | VI4F0K069V |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|